Eli Lilly reduces the price of its obesity medication, Zepbound®, offering discounted single-dose vials to expand access for self-pay patients with an on-label prescription. Learn more about this cost-cutting initiative.

Combining GLP-1 drugs like liraglutide with exercise helps maintain bone health during weight loss, according to a recent study. Learn how this approach can balance weight loss and bone density preservation.

The fitness industry is currently navigating new terrain with the emergence of GLP-1 and weight-loss drugs, sparking a debate on integrating these medical advances into fitness programs. This comes at a time when media mogul Oprah Winfrey revisited television with a special that highlighted the complexities of obesity as a disease and the potential life-altering impact of weight-loss medications such as Wegovy and Zepbound.